1924 related articles for article (PubMed ID: 16095545)
1. Systematic review on urine albumin testing for early detection of diabetic complications.
Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
[TBL] [Abstract][Full Text] [Related]
2. Preventing end-stage renal disease.
Mogensen CE
Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure control for diabetic retinopathy.
Do DV; Han G; Abariga SA; Sleilati G; Vedula SS; Hawkins BS
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD006127. PubMed ID: 36975019
[TBL] [Abstract][Full Text] [Related]
4. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.
Goa KL; Haria M; Wilde MI
Drugs; 1997 Jun; 53(6):1081-105. PubMed ID: 9179532
[TBL] [Abstract][Full Text] [Related]
5. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
McKenna K; Thompson C
Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
[TBL] [Abstract][Full Text] [Related]
6. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.
Mogensen CE
J Intern Med; 2003 Jul; 254(1):45-66. PubMed ID: 12823642
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure control for diabetic retinopathy.
Do DV; Wang X; Vedula SS; Marrone M; Sleilati G; Hawkins BS; Frank RN
Cochrane Database Syst Rev; 2015 Jan; 1():CD006127. PubMed ID: 25637717
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive agents for preventing diabetic kidney disease.
Lv J; Perkovic V; Foote CV; Craig ME; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2012 Dec; 12():CD004136. PubMed ID: 23235603
[TBL] [Abstract][Full Text] [Related]
9. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
[TBL] [Abstract][Full Text] [Related]
10. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
Sjølie AK; Chaturvedi N; Fuller J
Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
[TBL] [Abstract][Full Text] [Related]
11. WITHDRAWN: Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
Lovell HG
Cochrane Database Syst Rev; 2007 Jul; (1):CD002183. PubMed ID: 17636698
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
Lovell HG
Cochrane Database Syst Rev; 2001; (1):CD002183. PubMed ID: 11279757
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
[TBL] [Abstract][Full Text] [Related]
15. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P
Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971
[TBL] [Abstract][Full Text] [Related]
16. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
Cooper ME
J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
[TBL] [Abstract][Full Text] [Related]
17. Renal protection by antihypertensive drugs: insights from microalbuminuria studies.
Redon J
J Hypertens; 1998 Dec; 16(12 Pt 2):2091-100. PubMed ID: 9886902
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
Lovell HG
Cochrane Database Syst Rev; 2000; (2):CD002183. PubMed ID: 10796871
[TBL] [Abstract][Full Text] [Related]
19. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
Wang B; Wang F; Zhang Y; Zhao SH; Zhao WJ; Yan SL; Wang YG
Lancet Diabetes Endocrinol; 2015 Apr; 3(4):263-74. PubMed ID: 25660574
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
